1. The intermediates of biochemical cycles are commonly utilized for biosynthetic processes ; thus at least one intermediate must be replenished de novo to provide constant flux through the cycle. The utilization of L-arginine for NO synthesis in macrophages may thus reduce the concentration of intermediates of the urea cycle. It is possible that a glutamine-utilizing pathway exists in mononuclear phagocytes that may connect with the urea cycle.
INTRODUCTION
Like all cells of the immune system, macrophages are derived from pluripotent stem cells located in the bone marrow [1] . The macrophage is one of the principle cells capable of secreting a large number of compounds including nitric oxide (NO), hydrogen peroxide (H # O # ) and pro-inflammatory cytokines (for a review see [2] ).
Nitric oxide is a known secretory effector of macrophage antibacterial and anti-tumour activity [3] . Nitric oxide is also known to play an important role in the autoimmune destruction of pancreatic islet cells [4] . Recent evidence has also implicated NO in the pathogenesis of many immune-mediated diseases including glomerulonephritis, arthritis and many allergic skin and lung reactions. Production of NO may also be involved in allograft rejection (for a review see [5] ).
Nitric oxide production occurs via a 5-electron oxidation of L-arginine producing NO and citrulline [6] . The synthesis of NO has been reported in many cell types including macrophages [7] , neutrophils [8] , endothelial cells [9] and hepatocytes [10] . A number of nitric oxide synthase (NOS) isoforms are known to exist in various cells : endothelial constitutive (135 kDa), neuronal constitutive (150-160 kDa) and inducible (130 kDa) (for a review see [11] ).
Macrophage NO synthesis occurs via the NADPHdependent inducible NOS enzyme located in the cell cytosol [12] . The inducible form of NOS (iNOS) is expressed in a number of cell types including macrophages [13] , neutrophils [14] , lung fibroblasts [15] and epithelial cells [16] . It has been reported that the antitumour activity of macrophages depends upon the metabolism of L-arginine to citrulline and NO [17] ; thus it is widely accepted that NOS activity depends upon the presence of L-arginine and the source of this L-arginine is primarily exogenous [18] . However, the importance of extracellular L-arginine in vivo is more difficult to quantify. The concentration of L-arginine in blood is approximately 0.08-0.10 mM (compared with 0.4 mM in most types of tissue culture media). Activated macrophages can secrete arginase [19] , thus depleting the local exogenous L-arginine concentration. Alternative sources of L-arginine could be intracellular protein degradation or endogenous synthesis. The major sites of L-arginine synthesis in terrestrial vertebrates are liver (as part of the urea cycle) and kidney where arginine is synthesized from citrulline and released into the circulation (see [20] for a review). Possible routes for the synthesis of endogenous L-arginine in macrophages have only been partially explored. The synthesis of L-arginine from citrulline has been demonstrated previously in kidney cells [21] , aortic endothelial cells [22] and, more recently, macrophages [23] . The synthesis of citrulline from glutamine in turn has been demonstrated in enterocytes [24] and liver, but has not yet been demonstrated in other cells. It has been reported previously that glutamine plays an important role in macrophage function [25] .
The objective of this study was to examine the utilization of glutamine in murine macrophages and investigate the possibility that a pathway exists to convert L-glutamine to L-arginine and ultimately NO or urea (the latter may be formed by the enzyme arginase which can compete with iNOS for their common substrate Larginine). Arginase activity measurements were made both intra-and extracellularly to determine the conditions required to promote secretion of arginase and thus the ability to generate NO via intracellular iNOS. We have demonstrated previously that glutamine oxidation increases in macrophages exposed to the immunostimulants lipopolysaccharide (LPS) and interferon-γ [26] . Controversy exists concerning the ability of human monocytes to produce measurable quantities of NO, even though iNOS expression is detectable [27] . We thus measured glutamine utilization, nitrite synthesis and the activities of enzymes in the proposed L-arginine biosynthetic pathway in freshly isolated human monocytes in the absence of extracellular L-arginine to determine the appropriate conditions in which monocytes can produce NO.
MATERIALS AND METHODS

Materials
Bacillus Calmette-Guerin (BCG) was obtained from Evans Medical Ltd (Leatherhead, Surrey, U.K.). Dulbecco's modified Eagle's medium, Dulbecco's amino-acid-deficient medium and tissue culture amino acids were obtained from Gibco Ltd (Paisley, Scotland, U.K. 
Animals
Male CD1 mice (about 12 weeks of age) were obtained from The Biomedical Research Facility (UCD, Dublin, Ireland).
Peritoneal macrophage preparation
Resident cells present in the peritoneal cavity of at least 10 CD1 mice were collected after intraperitoneal injection of 5 ml of sterile PBS. Activated macrophages were obtained by the lavage of the cavity of at least 10 mice (using PBS) 7 days after intraperitoneal injection of 0.1 ml of BCG (approx. 1i10' bacteria per mouse). Cells were pooled and then cultured at a density of 2i10' cells per well.
Human circulating monocyte preparation
Circulating human monocytes were obtained from whole blood of healthy subjects by initially mixing with a 1 : 1 volume of dextran and then removing pelleted erythrocytes after a 45-min incubation at room temperature. Monocytes were separated from neutrophils in the supernatant by centrifugation for 30 min at 400 g after adding to lymphoprep. Monocytes were purified from lymphocytes via adherence to tissue culture plastic by incubation for 4 h at 37 mC in 95 % air and 5 % CO # . This procedure yielded a population of cells that was 95 % monocytes [27] . After pooling cells were cultured at a density of 2i10' cells per well. All calculations were based on results from experiments involving monocytes obtained from at least three healthy subjects.
Incubation procedure
After cell purification via adherence to tissue culture plastic for 4 h the medium was removed and the cells were washed vigorously three times with sterile PBS. The adherent cells were then cultured in fresh media in the presence of 0.1 % BSA (fatty acid free), 100 i.u.\ml penicillin and 100 µg\ml streptomycin, of defined composition (see results for further details) for up to 48 h.
Nitrite and nitrate release
Nitrite production was determined spectrophotometrically via incubation of 100 µl aliquots of supernatant sample media with an equal volume of Griess reagent (containing 0.1 % naphthylenediamine dihydrochloride, 1 % sulphanilamide and 2.5 % H $ PO % ) for 10 min at room temperature then reading A &&! using a Molecular Devices V max plate reader. Nitrite concentration was determined using NaNO # as standard. Nitrate was determined via conversion of nitrate to nitrite by nitrate reductase (0.1 unit\ml) in the presence of 50 µM NADPH and 5 µM FAD. However, results from preliminary experiments suggested macrophages can produce nitrate via a process that could not be inhibited by the iNOS inhibitor L-N5-(1-iminoethyl)ornithine hydrochloride (L-NIO). Therefore we did not incorporate nitrate production rates into the results presented here. 
Urea production
Glutamine utilization
Glutamine concentration was measured as described by Windmueller and Spaeth [28] . Briefly, glutamine was converted to glutamate and ammonia in the presence of the enzyme asparaginase and the subsequent reaction of ammonia to form glutamate and NAD + in the presence of 50 mM potassium phosphate buffer (pH 8.0), 0.2 mM NADH, 20 units\ml glutamate dehydrogenase, 5 units\ml asparaginase, 0.5 mg\ml BSA, 0.2 mM α-ketoglutarate and 15 % glycerol was followed by measuring the change in A $%! over 1 h.
Measurement of enzyme activities in macrophage and monocyte homogenates
After isolation macrophages or monocytes were maintained in cell culture in the absence of exogenous arginine for 48 h. Cell homogenates were prepared via homogenization on ice, in lysis buffer (containing 20 mM EDTA, 5 mM Tris\HCl and 0.5 % Triton X-100, pH 8.0). Cell homogenates were stored under liquid nitrogen until required for examination. Phosphatedependent glutaminase (EC 3.5.1.2) activity was assayed at 37 mC for 10 min via the sampling method (glutamate formation) described by Curthoys and Lowry [29] . The assay mixture contained 50 mM potassium phosphate buffer (pH 8.2), 0.2 mM EDTA, 50 mM Tris\HCl, 20 mM glutamine, 0.05 % (v\v) Triton X-100 and 200 µl of cell homogenate. Glutamate formation was determined as described by Bernt and Bergmeyer [30] . Pyrrolline-5-carboxylate synthase (EC number not assigned) activity was assayed at room temperature for 30 min via measurement of the reduction of [U-"%C]glutamate to [U-
"%C]pyrrolline-5-carboxylate which can then be quantified directly by use of liquid scintillation spectroscopy, as described by Kramer et al. [31] . Ornithine aminotransferase (EC 2.6.1.13) activity was measured for 15 min at 37 mC as described by Herzfeld and Knox [32] , based upon the colorimetric reaction of pyrrolline-5-carboxylate with o-aminobenzaldehyde. Ornithine carbamoyltransferase (EC 2.1.3. 
Arginase activity
Internal and external arginase activity was determined by measurement of urea production after incubation of 200 µl aliquots of sample supernatant media or cell homogenate for 4 h at 37 mC in the presence of tissue culture concentrations of L-arginine (0.4 mM) and 100 mM MnCl # . Cell homogenates were prepared as described previously and urea production was determined as described above.
Cell viability
Trypan Blue exclusion and measurement of lactate dehydrogenase release were used as a measure of cell viability for all conditions and time points reported in this paper. Cell viability was initially determined as 94 %, decreasing to 80 % after 48-h culture for all conditions reported here.
Expression of results
Results are expressed either on the basis of cell protein which was determined using a Sigma protein assay kit (Cat. No P5656) or alternatively expressed per 10' cells. Values are expressed as meanspS.E.M.
Statistics
Results are expressed as meanspS.E.M. unless otherwise indicated. Determination of statistical significance was performed using Student's t-test provided by the package ' Statworks '.
RESULTS
Effect of exogenous L-arginine and LPS on glutamine utilization by murine macrophages and human monocytes
Macrophages consume relatively large amounts of glutamine [34] [35] [36] . The importance of glutamine metabolism to macrophage function has been reported previously [25] . However, a systematic study of glutamine utilization by resident or BCG-activated murine macrophages or human monocytes in different culture conditions has not been reported. Here we report glutamine utilization rates in the latter cell types in the presence or absence of arginine or glucose. The cells were initially cultured for 24 or 48 h and then placed in fresh media and their glutamine utilization rates determined (Table 1) . Glutamine utilization rates varied from a minimum of approximately 20 nmol:h −" :mg −" protein for resident macrophages and monocytes (after 24 h of culture) to a maximum of approximately 100 nmol:h −" :mg −" protein in all three cell types in the absence of extracellular arginine. The rate of glutamine utilization increased as the period of time the cells were in culture increased for all three cell types. In addition, resident macrophage or monocyte glutamine utilization rates increased in the absence of extracellular glucose but the converse was found for BCG-activated macrophages (suggesting glutamine metabolism may be more directly dependent on glucose metabolism in the activated cell than in the resident cell or monocyte).
Incubation of macrophages or monocytes in the presence of bacterial LPS over 24 or 48 h increased glutamine utilization rates except in activated macrophages cultured in the absence of both glucose and arginine for 24 h or human monocytes cultured for 48 h ( Table 1) .
Effect of culture period, concentration of exogenous L-arginine, or addition of LPS on nitrite production by resident or activated murine macrophages or human monocytes
Nitrite (a stable product of NO oxidation) production from macrophages and monocytes was determined over a 1-h incubation period after an initial 4, 24 or 48 h in culture. This period of incubation was chosen as nitrite production from all three cell types was determined to be linear for at least 1 h in the conditions described. In the presence of tissue culture concentrations of exogenous Larginine (0.4 mM) nitrite production increased with the time of pre-culture (up to 48 h) in both BCG-activated macrophages (from 12.6 to 46.3 nmol:h −" :mg −" protein) and monocytes (8.3 to 30.3 nmol:h −" :mg −" protein, Table 2 ). If the exogenous L-arginine concentration was reduced to 0.06 mM then the time-dependent increase in nitrite production was substantially reduced in BCGactivated macrophages. If exogenous L-arginine was omitted from the culture medium then, as expected, no nitrite production could be detected from resident or BCG-activated macrophages after 4 or 24 h of preculture. However, after a period of 48 h pre-culture, detectable levels of nitrite were produced by resident and activated macrophages and monocytes (4.8-15.2 nmol:h −" :mg −" protein). Inclusion of the iNOS inhibitor L-NIO reduced nitrite production to undetectable levels in the latter experiments (results not shown).
Addition of 15 µg\ml LPS to the culture medium significantly increased nitrite production during the 1-h incubation period in BCG-activated macrophages precultured in the presence of 0.4 mM L-arginine for 4 h (P 0.01 or 24 h (P 0.01) and in the presence of 0.06 mM L-arginine for 24 h (P 0.05). Nitrite production was significantly increased in resident macrophages pre-cultured in the presence of 0.4 mM (P 0.01) and in the presence of 0.06 mM (P 0.05) L-arginine for 4 h or 24 h (Table 2) . After 48 h pre-culture in the absence of exogenous L-arginine LPS significantly increased nitrite Regulation of nitrite synthesis in macrophages and monocytes Table 1 Glutamine utilization rates in resident and activated murine macrophages and human monocytes Cells were isolated and purified via adherence to tissue culture plastic as previously described. After purification cells were pre-incubated for 24 or 48 h at 37 mC, in 95 % air and 5 % CO 2 , in selected tissue culture media supplemented with a combination of 2 mM glutamine with or without 5 mM glucose or 0.4 mM L-arginine. After pre-incubation the media was replaced and the cells were incubated for 1 h under the conditions described below in fresh media, and glutamine utilization was determined as described in the Methods section. Glutamine utilization was linear over this period. P values, where indicated, refer to the statistical difference between glutamine utilization in the presence of 15 µg/ml LPS compared with in its absence. Values are expressed as meanspS.E.M. of three or more incubations. *P 0.05 ; †P 0.01. ND, not determined. Table 2 Nitrite production in resident and BCG-activated murine macrophages and human monocytes
Peritoneal murine macrophages were isolated and purified as previously described. Human monocytes were obtained and cultured as previously described. After purification via adherence to tissue culture plastic, cells were cultured for 4, 24 or 48 h at 37 mC, in 95 % air and 5 % CO 2 in tissue culture media supplemented with 2 mM glutamine and 5 mM glucose in the absence or presence of varying concentrations of L-arginine. After pre-incubation the media was replaced and the cells were incubated for 1 h under the conditions described below, after which nitrite production was determined. Nitrite production was linear over this period. P values, where indicated, refer to statistical difference between glutamine utilization in the presence of 15 µg/ml LPS compared with in its absence. 
Enzyme activities from the proposed pathway ; glutamine to ornithine
The accepted pathway for conversion of L-glutamine to L-ornithine is Gln Glu, then Glu Orn via glutamate semialdehyde (and spontaneous interconversion to pyrroline-5-carboxylate [37] ). The activities of resident and activated macrophage and human monocyte phosphate-dependent glutaminase, pyrroline-5-carboxylate synthase, ornithine aminotransferase, ornithine carbamoyltransferase and carbamoyl-phosphate synthase (types I [NH %*+
-dependent] and II [glutaminedependent]) are reported in Table 3 . The activity of phosphate-dependent glutaminase in BCG-activated macrophages (139.25 nmol:min −" :mg −" protein) was similar to that reported previously for thioglycollateelicited murine macrophages (152 nmol:min −" :mg −" protein [34] ). Resident macrophage and human monocyte glutaminase activity was 40 % and 62 % of that found in BCG-activated macrophages respectively. The activity of pyrroline-5-carboxylate synthase in macrophages and monocytes is at least 30-fold higher than that reported for pig enterocytes [24] or intestinal mucosa cells [38] . However, the latter studies used a glutamate concentration of 1 mM in their assay. As the glutamine utilization rates and glutaminase activities are high for macrophages and monocytes we increased the glutamate concentration in our assay to 20 mM. The activity of ornithine aminotransferase in macrophages and monocytes was similar to that reported for pig enterocytes [24] . Ornithine carbamoyltransferase activity in macrophages and monocytes was approximately one-third of the activity reported for liver [39] , and considerably higher than the activity reported previously in macrophages [40] . The previous macrophage study involved the use of incubated freshly isolated cells (not cultured for 48 h as in this study) and a discontinuous colorimetric assay of citrulline, whereas in this study we used a more sensitive radiochemical assay to determine citrulline formation. The activity of macrophage and monocyte carbamoylphosphate synthase determined in this study was similar to that reported for pig enterocytes [24] .
Effect of addition of glutamine, glutamate, ornithine, citrulline, arginine or proline on nitrite or urea production from digitoninpermeabilized macrophages or monocytes
Addition of proposed intermediates in the pathway of Larginine biosynthesis from L-glutamine (at a concentration of 10 mM) caused significant increases in nitrite production in both digitonin-permeabilized BCGactivated macrophages (Figure 1a ) and monocytes (Figure 1b) . Addition of 10 mM glutamine or glutamate to permeabilized BCG-activated macrophages caused an approximate 6-fold elevation in nitrite production compared with incubation in standard tissue culture media (in the absence of L-arginine). Incubation in the presence of 10 mM ornithine, citrulline or arginine caused an elevation in nitrite production of approximately 5-, 3-and 3-fold respectively. Addition of 10 mM proline did not significantly (P 0.05) elevate nitrite production above control values. Addition of the iNOS inhibitor L-NIO effectively abolished nitrite production in all the above conditions. Production of nitrite from permeabilized human monocytes was approximately 2-fold that found for BCG-activated macrophages for control incubations (approximately 11 nmol nitrite:h −" :mg −" protein, Figure  1b) . Addition of 10 mM glutamine, glutamate, ornithine or arginine elevated nitrite production approximately 2-fold. Addition of proline did not significantly (P 0.05) elevate nitrite production above control values. Addition of the iNOS inhibitor L-NIO also effectively abolished nitrite production in all the above conditions. We also determined the effect of addition of 10 mM glutamine, glutamate, ornithine, citrulline, arginine or proline on digitonin-permeabilized macrophage or monocyte urea Regulation of nitrite synthesis in macrophages and monocytes Cells were isolated and purified as described previously. After initial purification the cells were pre-incubated for 48 h at 37 mC in 95 % air/5 % CO 2 in L-argininedepleted media containing 2 mM glutamine and 5 mM glucose. Activated murine macrophages (a) were incubated in the presence of 15 µg/ml bacterial LPS. Human monocytes (b) were incubated in the absence of LPS. After pre-incubation the cells were permeabilized for 30 min with 0.5 mM digitonin as described in Materials and Methods with or without 100 µM L-NIO (an iNOS inhibitor), and then incubated for 1 h in the presence of standard tissue culture medium (in the absence of L-arginine unless otherwise indicated) j/k10 mM of selected metabolites with or without L-NIO, after which nitrite release was determined. Statistical differences between nitrite production rates from cells incubated in metabolite-supplemented culture media compared with cells cultured in nonsupplemented media are indicated by : *P 0.05, jP 0.01.
production. The rate of urea production in BCGactivated macrophages in the presence of standard tissue culture concentrations of the above substrates (in the absence of L-arginine) was 1.76 µmol:h −" :mg −" protein whereas in human monocytes the rate was 1.38 µmol:h −" :mg −" protein ( Table 4 ). The rate of urea production was increased to a maximum of 2.16 µmol:h −" :mg −" protein in BCG-activated macrophages in the presence of 10 mM arginine, while in monocytes it was increased to a maximum of 1.83 µmol:h −" :mg −" protein. As the rate of the urea cycle in macrophages is high, the presence of nitrogen-donating amino acids in the culture medium would explain the Table 4 Rates of urea production in permeabilized cells exposed to 10 mM of pathway intermediates Cells were isolated and purified as previously described. After initial purification the cells were pre-incubated for 48 h at 37 mC, in 95 % air and 5 % CO 2 , in Larginine-depleted media supplemented with 2 mM glutamine and 5 mM glucose. BCG-activated macrophages were incubated in the presence of 15 µg/ml bacterial LPS. Human monocytes were incubated in the absence of bacterial LPS. Cells were permeabilized by incubation under the above conditions for 30 min with 0.5 µM digitonin and then incubated for 1 h in the presence of 10 mM metabolite as described below. Values are expressed as meanspS.E.M. of three or more incubations. Statistical significance is indicated if the addition of metabolite to the cell culture media described above resulted in a difference in urea production compared with incubation in its absence (control). *P 0.05, †P 0.01. high rate of urea production in the absence of additional glutamine, glutamate, ornithine, citrulline or arginine (' control ' data, Table 4 ). Addition of the iNOS inhibitor, L-NIO, did not significantly increase urea production in permeabilized macrophages or monocytes in the presence of 10 mM arginine (results not shown).
Effect of the glutaminase inhibitor 6-diazo-5-oxo-norleucine on nitrite production from murine resident and BCG-activated macrophages or human monocytes
Resident and BCG-activated macrophages or human monocytes were cultured over 48 h in L-arginine-depleted media in the presence of varying concentrations of 6-diazo-5-oxo-norleucine. They were then tested for their ability to produce nitrite over 1 h, in the absence of 0.4 mM extracellular arginine (fresh arginine-deficient culture medium). The production of nitrite was reduced to a minimum of 6-7 nmol:h −" :mg −" protein in both cell types as the concentration of glutaminase inhibitor in the culture medium was increased up to 200 µM (Figure 2 ).
Arginase secretion from resident and BCGactivated macrophages or human monocytes
Arginase activity in resident or activated macrophages and in the surrounding culture medium was determined over time in the absence of extracellular L-arginine. There was a direct correlation between a drop in intracellular Cells were isolated and purified via adherence to tissue culture plastic as described previously. After initial purification the adherent cells were pre-incubated for 48 h at 37 mC in 95 % air/5 % CO 2 in L-arginine-depleted media containing 2 mM glutamine and 5 mM glucose in the presence of varying concentrations of glutaminase inhibitor. Activated murine macrophages were incubated in the presence of 15 µg/ml bacterial LPS. Resident macrophages and human monocytes were incubated in the absence of LPS. After pre-incubation, nitrite production over 1 h in fresh tissue culture media (in the absence of arginine) was determined as described in Materials and Methods. Statistical differences between nitrite production rates from cells incubated with inhibitor compared with cells cultured in non-supplemented media are indicated by : *P 0.05, jP 0.01.
arginase activity and the appearance of arginase in the culture medium (Figure 3 ). The intracellular arginase activity was initially similar in both cell types (approximately 7-7.5 µmol urea:4 h −" :mg −" protein) and was substantially reduced over a period of 24 h. However, substantial concentrations of extracellular arginase were detected after only 1 h in the culture medium surrounding BCG-activated macrophages, and this rose to a maximum detectable level of 6-7 µmol urea:4 h −" :mg −" protein after 24 h. The extracellular concentration of Cells were isolated and purified via adherence to tissue culture plastic as described previously. Cells were cultured at 37 mC in 95 % air/5 % CO 2 in L-arginine-depleted media containing 2 mM glutamine and 5 mM glucose for up to 48 h, during which time samples of supernatant media and cell homogenate were obtained to determine external and internal arginase activity respectively via urea production as described in Materials and Methods.
arginase in medium surrounding resident macrophages increased more slowly, reaching a maximum of approximately 2.5 µmol urea:4 h −" :mg −" protein after 48 h. The arginase secretion profile of human monocytes was similar to that of resident macrophages (Figure 3 b) .
DISCUSSION
It is known that both iNOS and arginase activities are higher in activated macrophages (activated by LPS or interferon-γ) than in resident cells [41] [42] [43] . We report here that glutaminase activity is also increased after macrophage activation (Table 3) . However, the connection between glutaminase activity and NO production has not been explored previously. The initial link between glutamine utilization and nitrite production was implied by the finding that glutamine utilization by Regulation of nitrite synthesis in macrophages and monocytes
Figure 4 Macrophage L-arginine metabolism
The proposed pathway from L-glutamine to L-arginine in the murine macrophage and human monocyte is illustrated. Part of this pathway has been described previously [23] .
macrophages and monocytes was substantially increased in the absence of extracellular arginine. Nitrite production could not be detected in resident or BCGactivated macrophages cultured in the absence of extracellular arginine for 4 or 24 h nor in monocytes cultured for 4 h. These results are in broad agreement with previous reports [44, 45] . However, after 24 or 48 h, detectable nitrite production rates were reported for monocytes and macrophages respectively, cultured in the absence of arginine. The ability of macrophages to respond to LPS by increasing nitrite production rates appeared to depend on exogenous arginine concentration and time of culture. We suggest that glutamine can be converted to the substrate for iNOS, arginine, allowing NO production in the absence of extracellular arginine in macrophages and monocytes. To obtain further evidence to support this hypothesis we have measured the activity of enzymes that would form the proposed pathway from glutamine to citrulline (see Figure 4 for clarity). The conversion of citrulline to arginine in macrophages has been reported previously [23] . Substantial activities of the enzymes phosphate-dependent glutaminase, pyrroline-5-carboxylate synthase, ornithine aminotransferase, ornithine carbamoyltransferase and carbamoyl-phosphate synthase (types I and II) are all present in macrophages and monocytes. The activities of these enzymes are all well in excess of our reported rates of nitrite production in the absence of arginine.
Addition of intermediates in the proposed glutamine arginine pathway to digitonin-permeabilized macrophages or monocytes caused substantial increases in nitrite. Addition of proline, however, did not significantly increase nitrite production rates. Proline could feasibly be converted to pyrroline-5-carboxylate and hence to ornithine and arginine. However, the latter pathway appeared not to influence nitrite production in macrophages and monocytes. The addition of glutamine, glutamate or ornithine to macrophages all resulted in a higher rate of nitrite production compared with the addition of arginine. This could be due to ornithinedependent product inhibition of arginase. The iNOS inhibitor L-NIO dramatically reduced nitrite formation in all conditions, demonstrating that the elevated nitrite production that occurred on the addition of proposed pathway intermediates was iNOS dependent. Culture of macrophages or monocytes in the presence of the glutaminase inhibitor 6-diazo-5-oxo-norleucine for 48 h lowered their ability to produce nitrite in a dosedependent manner (Figure 2) , thus demonstrating that inhibition of the enzyme catalysing the first step in the proposed pathway leads to inhibition of the production of the end-product, nitrite.
The rate of urea synthesis is substantially greater ( 50-fold) than nitrite production. The increase in urea production in the presence of 10 mM arginine was less than 1.4-fold in monocytes and 1.3-fold in macrophages (Table 4) . Ornithine produced by the action of arginase must therefore be converted back to arginine via enzymes of the urea cycle to account for the high control levels of urea production (urea production in the presence of tissue culture concentrations of amino acids described in Table 4 ). It is feasible that competition between intracellular arginase and iNOS could limit the production rates of NO and hence nitrite. In conditions in which extracellular arginine concentrations are low the ability of macrophages or monocytes to produce NO may thus be compromised. Macrophages and monocytes may respond to this problem by secreting arginase thus increasing the availability of intracellular arginine for iNOS. Evidence in support of this hypothesis is that intracellular arginase activity drops with respect to time of culture in the absence of extracellular arginine whereas extracellular arginase increases (Figure 3) . The period of pre-culture required for monocytes or macrophages to produce measurable quantities of nitrite coincides with the time taken for arginase to fall to minimum observable levels. There is thus a reciprocal correlation between intracellular arginase activity and nitrite production rates. The expression of iNOS is increased in BCG-activated macrophages compared with resident cells [46] , but due to its much greater activity the secretion of arginase may play a more important role in dictating the rate of NO synthesis. A number of groups have reported difficulty in measuring nitrite production from human monocytes ( [27] and references contained within). The culture conditions that they used (presence of 0.4 mM L-arginine, compared with its absence in our own experiments) may have altered patterns of arginase secretion such that little NO could be produced due to competition of iNOS and arginase for available arginine.
We have demonstrated the existence of a pathway for arginine synthesis from glutamine in macrophages and monocytes. We suggest that, in conjunction with secretion of arginase, this pathway can supply arginine at a rate sufficient to account for the observed rate of nitrite synthesis. In addition to its role as an oxidative fuel [36] glutamine thus serves an important function as precursor for arginine and thus NO biosynthesis.
